Lin, Andrew

Publications

Sort by

Co-Author Network

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma. Blood. 2018 Academic Article GET IT
Times cited: 197
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab. 2018 GET IT
Times cited: 105
Molecular and histologic characteristics of pseudoprogression in diffuse gliomas. Journal of neuro-oncology. 2016 Academic Article GET IT
Times cited: 28
Is there a role for early chemotherapy in the management of pituitary adenomas?. Neuro-oncology. 2016 Review GET IT
Times cited: 26
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro-oncology. 2013 Academic Article GET IT
Times cited: 23
Standardized patient outcomes trial (SPOT) in neurology. Medical education online. 2011 Academic Article GET IT
Times cited: 17